Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011;125(3):103-6.
doi: 10.1159/000321791. Epub 2010 Nov 24.

Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke

Affiliations
Case Reports

Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke

William J Savage et al. Acta Haematol. 2011.

Abstract

A 12-year-old boy with HbSS sickle cell disease (SCD) was admitted with an acute febrile illness and developed overt stroke 3 days later. Plasma glial fibrillary acidic protein levels were elevated, as compared to pediatric controls, 32 h prior to the clinical diagnosis of stroke, peaked immediately prior to the exchange transfusion, and remained elevated 1 year later despite chronic transfusion therapy. Stroke in SCD can occur in the setting of acute illness, and a biomarker that could predict the onset and triage ill children to therapeutic intervention more quickly would be useful.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Neuroimaging of acute stroke in a 12-year-old HbSS patient who had plasma GFAP followed serially. a Noncontrast head CT immediately after clinical diagnosis of stroke showing a wedge of hypoattenuation in the right frontal lobe (arrow). b FLAIR MRI image 29 h after clinical diagnosis of stroke showing an evolving right anterior cerebral artery infarct (arrow).
Fig. 2
Fig. 2
a Serial plasma GFAP levels in a 12-year-old patient with HbSS and acute stroke. A red cell exchange transfusion was performed 5 h after clinical diagnosis and again 47 h later for new neurologic deficits. The dotted line marks the 95th percentile value among 60 healthy pediatric controls. Arrowheads mark the presentation of relevant signs and symptoms. b Fifty-four weeks of follow-up GFAP measurements.

Similar articles

Cited by

References

    1. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–294. - PubMed
    1. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84:618–625. - PMC - PubMed
    1. Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009;114:5117–5125. - PubMed
    1. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–2778. - PubMed
    1. Woertgen C, Rothoerl RD, Wiesmann M, Missler U, Brawanski A. Glial and neuronal serum markers after controlled cortical impact injury in the rat. Acta Neurochir Suppl. 2002;81:205–207. - PubMed

Publication types